Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer

被引：0

作者：

Wei-Wei Peng

Ying Liu

Huan-Huan Sha

Shao-Di Wen

Ying Fang

Guo-Ren Zhou

机构：

[1] Jiangsu Institute of Cancer Research,Jiangsu Cancer Hospital

[2] The Affiliated Cancer Hospital of Nanjing Medical University,undefined

来源：

BMC Pulmonary Medicine | / 23卷

关键词：

Non-small cell lung cancer (NSCLC); Plasma cell-free DNA (cfDNA); Prognosis biomarkers;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] THE RELATIONSHIP BETWEEN CELL-FREE PLASMA DNA CONCENTRATION AND MORTALITY OF ICU PATIENTS
Aoyama, M.
Kotani, J.
Ueda, T.
Maeshige, N.
Miyoshi, M.
Oka, N.
Inoue, T.
Usami, M.
SHOCK, 2012, 37 : 111 - 111
[42] Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease
Szpechcinski, A.
Chorostowska-Wynimko, J.
Struniawski, R.
Kupis, W.
Rudzinski, P.
Langfort, R.
Puscinska, E.
Bielen, P.
Sliwinski, P.
Orlowski, T.
BRITISH JOURNAL OF CANCER, 2015, 113 (03) : 476 - 483
[43] Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease
A Szpechcinski
J Chorostowska-Wynimko
R Struniawski
W Kupis
P Rudzinski
R Langfort
E Puscinska
P Bielen
P Sliwinski
T Orlowski
British Journal of Cancer, 2015, 113 : 476 - 483
[44] Circulating cell free DNA during chemo-radiotherapy in non-small cell lung cancer patients
Nygaard, L.
Ahlborn, L.
Persson, G.
Chandrananda, D.
Langer, J.
Fischer, B. M.
Aznar, M.
Langer, S.
Gabrielaite, M.
Kjaer, A.
Rosenfeld, N.
Mouliere, F.
Ostrup, O.
Vogelius, I.
Bentzen, S.
RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S747 - S748
[45] Detection of EGFR Mutations in Circulating Cell-Free DNA (cfDNA) from Plasma Samples of Patients with Non-Small Cell Lung Cancer Using the Oncomine Lung cfDNA Assay
Anand, S.
Matharu, B.
Lu, W.
Dimastrogiovanni, D.
Butler, C.
Verrissimo, T.
Harden, S.
Gilligan, D.
Jones, A.
Scott, M.
Liu, H.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (03): : S18 - S19
[46] The relationship between weight gain during chemotherapy and outcomes in patients with advanced non-small cell lung cancer
Roeland, Eric J.
Fintelmann, Florian J.
Hilton, Fiona
Yang, Ruoyong
Whalen, Ed
Tarasenko, Lisa
Calle, Roberto A.
Bonomi, Philip D.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (03) : 1030 - 1040
[47] Monitoring treatment response in EGFR mutant non-small cell lung cancer patients using mutational load in circulating cell-free tumour DNA.
Taus, Alvaro
Hernandez, Ainhoa
del Carmen Vela, Maria
Martinez, Gemma
Piquer, Gabriel
Correa, Roser
Longaron, Raquel
Vidal, Joana
Casadevall, David
Pijuan, Lara
Montagut, Clara
Serrano, Sergi
Albanell, Joan
Arriola, Edurne
Bellosillo, Beatriz
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[48] Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
Schmidt, Bernd
Beyer, Julia
Dietrich, Dimo
Bork, Ines
Liebenberg, Volker
Fleischhacker, Michael
PLOS ONE, 2015, 10 (02):
[49] Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer
Guibert, Nicolas
Jones, Greg
Beeler, John F.
Plagnol, Vincent
Morris, Clive
Mourlanette, Jean
Delaunay, Myriam
Keller, Laura
Rouquette, Isabelle
Favre, Gilles
Pradines, Anne
Mazieres, Julien
LUNG CANCER, 2019, 137 : 1 - 6
[50] Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer
Fernandes, Maria Gabriela O.
Cruz-Martins, Natalia
Souto Moura, Conceicao
Guimaraes, Susana
Pereira Reis, Joana
Justino, Ana
Pina, Maria Joao
Magalhaes, Adriana
Queiroga, Henrique
Machado, Jose Carlos
Hespanhol, Venceslau
Costa, Jose Luis
CANCERS, 2021, 13 (11)

← 1 2 3 4 5 →